Mesoporous Materials for Drug Delivery

Abstract Research on mesoporous materials for biomedical purposes has experienced an outstanding increase during recent years. Since 2001, when MCM‐41 was first proposed as drug‐delivery system, silica‐based materials, such as SBA‐15 or MCM‐48, and some metal–organic frameworks have been discussed as drug carriers and controlled‐release systems. Mesoporous materials are intended for both systemic‐delivery systems and implantable local‐delivery devices. The latter application provides very promising possibilities in the field of bone‐tissue repair because of the excellent behavior of these materials as bioceramics. This Minireview deals with the advances in this field by the control of the textural parameters, surface functionalization, and the synthesis of sophisticated stimuli‐response systems.